Copy
Newsletter November/December 2019 EIT Health UK-Ireland
Dear EIT Health Partners & Friends, 

EIT Health Summit, Matchmaking and European Health Catapult Finals have been among the many highlights we’ve enjoyed this month. 
 
December not only marks the beginning of the festive period, but also a key milestone in the call for BP2021, namely the Expression of Interest (EoI) submission deadline. The EoI deadline is a prerequisite for the next stage of the call process, so we were delighted to receive a high number of submissions from across the UK-Ireland partnership. We would like to thank all of those who submitted an EoI and you can expect to receive feedback and support with your submission in mid-January.
 
We also hosted EIT Health Summit, our largest networking event of the year, in Paris. Set in the beautiful Palais Brongniart, it was fantastic to see so many familiar faces throughout the two-day event. The Summit showcased thought-provoking keynote speakers, workshops and start-up exhibitions with the collective goal of defining unmet need when meeting healthcare’s biggest challenges. Thanks to those who journeyed to Paris and we hope you enjoyed the Summit as much as we did. Read on to learn more about the Summit, which featured two impressive start-ups from our CLC, Gasgon Medical and uFraction8, in the finals of Catapult.  
 
It is a bittersweet time for the CLC as we say goodbye to some valuable members of our team. We bid farewell to Kirstie Clegg and Lyn Markey, our dynamic duo from the Innovation team, and Kristen Stavridis, our energetic Business Creation Project Coordinator. Kirstie, Lyn and Kristen have had a huge impact on their respective programmes’ activities and their enthusiasm, commitment and passion will be greatly missed, both by the many partners they have worked with and those of us who have had the pleasure to work with them on a daily basis. We would like to express our sincere gratitude to them for all their hard work and, in light of these changes, we look forward to introducing you to our new starters in January.
 
And, lastly, as the year draws to a close, I wish to thank you for your continued patience, understanding and solidarity with regards to the uncertainty surrounding Brexit. In view of the election result last Thursday, we will disseminate a detailed update of our understanding on the implications for our network shortly. For now, however, I will emphasise our continued commitment to collaboration with our UK partners. 
 
I hope you all have a wonderfully festive and restorative Christmas and start to the new year, full of time with your loved ones, and we look forward to collaborating with you and supporting you with your proposals in the new year. 
 
Leslie Harris
EIT Health UK-Ireland Managing Director
EIT Health UK-Ireland
More than 1,000 delegates attend EIT Health Summit in Paris

Over 1,000 multidisciplinary stakeholders gathered in Paris for EIT Health Summit 2019 to answer the question, 'Defining unmet need – how much does it matter?'

Held on 2nd- 3rd of December at the Palais Brongniart in Paris, the Summit brought together some of the world’s leading experts to share invaluable, first-hand insights from the worlds of business, education, research and healthcare delivery to accelerate new-thinking – from building a clear need proposition for an idea, all the way through to successful adoption.

You can read more on the Summit here. 

EIT Health presents Venture Centre of Excellence programme at Summit

CEO of EIT Health, Jan-Philipp Beck, Managing Director of EIT Health France, Jean-Marc Bourez, and Head of Innovation & Alternative Financing Division at European Investment Fund, Tomasz Kozlowski, presented the EIT Health Venture Centre of Excellence (VCOE) programme in partnership with the European Investment Fund (EIF) in Paris.

The VCoE is a first-of-its-kind pan-European programme that aims to accelerate innovation through investment. It will address the fragmented regulatory and investment landscape across Europe by strengthening the relationships between venture funds, corporate investors and Europe’s most promising life sciences start-ups.

Register for Matchmaking in Berlin

Following on from successful Matchmaking events in Barcelona and Paris for the EIT Health Business Plan 2021, the third and final EIT Health Matchmaking event will take place on 4 to 6 February in Berlin.

Matchmaking Berlin will give you the chance to find the perfect matching Partner for your proposal – no matter if you are:
  • a Lead Partner and looking for more partners for your proposal
  • an EIT Health Partner and looking for an interesting project in which you can participate
  • a Start-up/External project partner looking for opportunities to be part of the EIT Health Community.
During the scheduled sessions and bootcamps you will receive feedback regarding important aspects such as problem-solution fit, go-to-market strategy, viability of the business model, risk and mitigation strategy and competition analysis.

You can register for Matchmaking hereRegistration closes on 17 January 2020.
CAMPUS
Forty graduates celebrate their graduation from EIT Health Master's Programmes 

Forty graduates from the four EIT Health Master's programmes celebrated their graduation at a ceremony held in Paris on 1 December. 

The four EIT Health Master programmes include:

All of these programmes have been awarded the EIT Label, which goes to Master and Doctoral programmes combining excellent scientific education with innovation and entrepreneurship training. 

For more information, visit: Degree Programmes

i-Days Final: Winning teams announced

On 1 December, the winning team from each of the 31 local Innovation Days (i-Days) attended the Winners Event in Paris to compete in a final pitch contest.

The top 3 winning i-Days teams are:

GOLD: Face Rehab from Innovlab Startup Center of T-Systems, Slovakia 
SILVER: Smart Umbrella from Riga Stradins University, Latvia 
BRONZE: BiotiPro from Universidad Politécnica de Madrid (UPM), Spain 


EIT Health i-Days

EIT Health i-Days are held at universities around Europe to promote health innovation among university students through one-to-two-day programmes held at academic institutions around Europe.
Health professionals participate in final innovation sprint

Participants of the Ambassadors in Healthcare Innovation (AHI) programme, a course which empowers health professionals to be innovative and turn their ideas into products and services, took part in a two-day design sprint at Tangent, Trinity's Ideas Workspace on 21 - 22 November.

The final innovation challenge encouraged those who participated in the 8-week course to apply their learnings to six healthcare challenges and, in groups, develop innovative solutions to them. The groups later pitched their ideas – in the form of products and services – to a jury and audience. 

The Ambassadors in Healthcare Innovation programme was awarded funding in 2019 as part of EIT Health's annual call for projects.
ACCELERATOR
UK-Ireland start-ups compete in European Health Catapult Final

UK-Ireland-based start-ups, Gasgon Medical (MedTech) and uFraction8 (BioTech), were awarded second and third in their respective categories in the European Health Catapult Finals at the EIT Health Summit on 2 December.

The top-prizes went to: SparingVision, with a treatment that can stop the progress of an inherited disease that causes blindness; PKvitality, with a smart watch for measuring blood sugar levels; and Epihunter, with an app that monitors difficult to detect "absence seizures" among epileptics.

European Health Catapult 2019

Three winners and six runners up were chosen from the 21 finalists, who had been training and competing since spring 2019 to reach the finals of the European Health Catapult (EHC). The biggest pitch contest organised by EIT Health, EHC is designed to identify and accelerate promising European start-ups in the categories of Biotech, Medtech and Digital Health. Along with cash awards of up to €40 000 for the winners and runners up, the contest provided a high-profile audience for all of the EHC competitors.

You can learn more about the nine Catapult finalists and their start-ups, here.

Three EIT Health supported start-ups to receive €17m under Disruptive Technologies Innovation Fund

EIT Health supported start-ups OmniSpirantLatch Medical and Tympany Medical are part of a cohort of  16 ground-breaking projects that have been successful under the second round of the Disruptive Technologies Innovation Fund administered by Enterprise Ireland. The 16 projects will share €65 million out to 2022, with OmniSpirant, Latch Medical and Tympany Medical sharing a total of €17 million. 

The start-ups, who have previously participated in competitions such as European Health Catapult and Headstart, will be developing and deploying their disruptive innovative technologies on a commercial basis with the aim of tackling national and global challenges to secure the jobs of the future.
  • OmniSpirant is developing inhaled bioengineered exosome therapeutics, delivered by tailored aerosol delivery technology for the treatment of Chronic Obstructive Pulmonary Disease (COPD).
  • Latch Medical is a company with a platform microneedle technology. The technology is centred around microneedles that can – almost painlessly – penetrate the outer layers of the skin, without the use of adhesive. 
  • Tympany Medical has developed a specialised endoscope for ear surgery in the form of a miniature device which will allow clinicians to see around corners, with unparalleled precision.
Join our Accelerator Slack Group for UK-Ireland Start-ups and SMEs

We have created an Accelerator Slack Group for UK-Ireland Startups and SMEs. Join to keep informed of upcoming deadlines, opportunities, and partner events. You may also use this forum to ask questions and share resources with each other, and we've created a special Channel for Job Postings. Don't worry, the team will continue to email you about the important things – like reporting.
 
Join our Accelerator Slack Group HERE
INNOVATION
Oxford based start-up gets €2M to combat Alzheimer's 

Oxford based startup, iLoF, brought together by the Wild Card competition – an EIT Health programme that supports projects in response to main health challenges – has been awarded two million euros to combat Alzhemier’s through artificial intelligence and photonics. 

iLof, based at the Oxford Foundry, has created a portable system that serves as a file for the fingerprints of various neurodegenerative diseases and allows rapid and non-invasive tests for diseases such as Alzheimer’s.

Dr Joana Paiva, one of the founders of iLoF says that the goal is now to “change the paradigm” of today, using methods such as artificial intelligence and photonics to “accelerate the development of new and personalised treatments” for Alzheimer’s disease. 

“Every three seconds someone in the world develops Alzheimer’s. Although there are 50 million people worldwide with Alzheimer’s, there has been no new treatment approved in the last 14 years and more than 400 clinical studies have failed. Another recognised fact is that the number of Alzheimer’s patients is expected to triple by 2050”.

Though their research and development arm is based at the Medical Research Centre at the University of Porto in Portugal, the start-up has secured a place at the Oxford Foundry until May next year as part of the OXFO L.E.V8 accelerator. The L.E.V8 accelerator is a six month accelerator providing high-potential Oxford University student and alumni-founded ventures with mentorship, masterclasses, access to a global network of industry experts, mentors, advisors and investors, free legal, business, finance, creativity, tech support and much more.

To learn more about the two winning Wild Card teams, read on here.
Wild Card 2020: Applications are OPEN!

Wild Card builds new ventures that push boundaries and troubleshoot some of European healthcare’s greatest challenges. Wild Card attracts the brightest talent, mentor founders‑to‑be and invest up to €2 million in the two most promising ventures.

The two challenge areas Wild Card 2020 is focused on are: advancing women’s health and progressing digital therapeutics.

Find out more here. Application deadline is 9 February 2020 23:59 CET.

Job Opportunities
EIT Health is hiring a new Senior Programme Manager, Gold Track 
 
EIT Health has an opening for a Senior Programme Manager (part-time or full-time) to lead and manage the Gold Track team in Europe. The Gold Track programme is a highly competitive initiative that offers emerging companies from Europe and Israel customised, strategic guidance to identify their North Star and create a roadmap to succeed in the global market. We are looking to fill the position as soon as possible.

Full position description and how to apply can be found here

Deadline for applications will remain open until a suitable candidate is found.
OTHER OPPORTUNITIES:
  • KEEP A LOOK OUT: EIT Health is offering student and research nurses & midwives a sponsorship opportunity to attend THEConference 2020. Details on the submission process to follow in January. 
Events EIT Health
04 - 06.02.2020 - Berlin, Germany - EIT Health Matchmaking event for BP2021
EITHealth_UKI EITHealth_UKI
clc.uk-ireland@eithealth.eu clc.uk-ireland@eithealth.eu
EITHealth EITHealth
Copyright © 2019 EIT Health UKI, All rights reserved.


Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.